RINVOQ® Shows Significant Efficacy in Severe Alopecia Areata: Phase 3 Results Signal Expanding Therapeutic Potential
Alopecia areata is an autoimmune disease that triggers sudden and often unpredictable hair loss that continues to pose significant challenges for both patients and clinicians. While recent FDA approvals of